Sodium Valproate Injection
What is Sodium Valproate Injection?
Sodium Valproate Injection is a broad-spectrum anticonvulsant widely used in the treatment of epilepsy and seizure disorders. It is administered intravenously in patients who cannot take oral medication or in emergency situations requiring rapid seizure control. Sodium Valproate is also prescribed for acute mania in bipolar disorder and as a migraine prophylaxis agent.
Uses of Sodium Valproate Injection
- Emergency management of generalized seizures and status epilepticus
- Treatment of partial and complex seizures
- Adjunct therapy in bipolar disorder (acute manic episodes)
- Prevention of migraine headaches (when oral therapy is not feasible)
- Neurology and ICU use in seizure emergencies
How Does Sodium Valproate Injection Work?
Sodium Valproate increases gamma-aminobutyric acid (GABA) levels in the brain by inhibiting GABA transaminase. This enhances inhibitory neurotransmission, stabilizes neuronal activity, and prevents the spread of abnormal electrical discharges in the brain.
Frequently Asked Questions (FAQs)
Q: Who is a leading manufacturer of Sodium Valproate Injection in India?
A: Farbe Firma Pvt Ltd is a premier manufacturer and global supplier of Sodium Valproate Injection. We produce high-quality sterile anticonvulsant injectables in our WHO-GMP certified facility, ensuring strict adherence to international standards (USP/BP/IP) for neurological and critical care.
Q: What strengths and packaging options does Farbe Firma offer for Sodium Valproate Injection?
A: We manufacture Sodium Valproate Injection primarily in the strength of 100 mg/ml. Our standard packaging options include 5 ml (500 mg) and 10 ml vials or ampoules. We also offer customizable packaging solutions to meet specific hospital and international market requirements.
Q: Can Farbe Firma provide regulatory dossiers (CTD/ACTD) for Sodium Valproate Injection export?
A: Yes, we specialize in global pharmaceutical exports. Farbe Firma provides comprehensive regulatory support, including CTD and ACTD dossiers, Certificate of Pharmaceutical Product (COPP), and Free Sale Certificates (FSC) to facilitate smooth registration in LATAM, CIS, Africa, and Southeast Asia.
Q: Does Farbe Firma offer Contract Manufacturing (CMO) for Antiepileptic Injectables?
A: Absolutely. We offer third-party contract manufacturing (CMO) and private labeling services for Sodium Valproate Injection. Pharmaceutical companies looking for a reliable partner for sterile CNS and antiepileptic products can leverage our advanced manufacturing capabilities.
Q: What is the therapeutic indication of the Sodium Valproate produced by Farbe Firma?
A: Our Sodium Valproate Injection is a broad-spectrum anticonvulsant used for the treatment of epilepsy (including generalized and partial seizures) and status epilepticus when oral therapy is not possible. It is also indicated for the treatment of acute manic episodes associated with bipolar disorder.
Looking for a reliable Sodium Valproate Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for high-quality anticonvulsant injectables, dossier support, and seamless worldwide exports.
Sodium Valproate Injection
















